MAOIs are deaminators of neurotransmitters, resulting in deactivation of, and affecting the number of, neurotransmitters in the synaptic cleft, thereby regulating neurotransmitter levels and brain mood function
Enhanced Fat Oxidation and Body Composition Improvement: The primary benefit documented in research is the enhancement of fat metabolism and reduction in body weight gain
Injury location: Areas with better blood supply typically heal faster than poorly vascularized tissues
In preclinical research, combined administration has demonstrated superior outcomes compared to either peptide administered alone for muscle, tendon, and ligament injuries
Concentration, Volume, and Purity Each vial contains the following peptide quantities: BPC-157 10 mg TB-500 10 mg GHK-Cu 50 mg KPV 10 mg The blend is supplied in a 5 mL multi-dose sterile vial , allowing convenient dilution and laboratory handling